Nieuws en evenementen

LumiraDx Receives WHO Emergency Use Listing for SARS-CoV-2 Ag Test

vrijdag 20 mei 2022

LumiraDx Five-Minute SARS-CoV-2 Ag Ultra Test Achieves CE Marking

donderdag 19 mei 2022

Bill Gates Ted Talk: We Can Make COVID-19 the Last Pandemic | Bill Gates | TED

vrijdag 29 april 2022

LumiraDx Receives UK MHRA Approval for SARS-CoV-2 RNA STAR Complete

maandag 21 februari 2022

LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Detects the Omicron Variant

vrijdag 14 januari 2022

LumiraDx Monitoring of New and Emerging Variants of Concern and Detection of the Omicron Variant

maandag 29 november 2021

LumiraDx receives approval for its COVID-19 Antigen Test for use in India

woensdag 20 oktober 2021

Bill & Melinda Gates Foundation’s Goalkeepers report features LumiraDx’s work in the fight against COVID-19

dinsdag 21 september 2021

LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics

vrijdag 20 augustus 2021

PLOS Medicine publishes systematic review and meta-analysis of more than 60 SARS- CoV-2 antigen tests: Ranks LumiraDx’s SARS-CoV-2 Ag Test as most sensitive and accurate

woensdag 18 augustus 2021

LumiraDx Receives FDA Emergency Use Authorization for its COVID-19 Antibody Test, Now Allowing COVID-19 Antigen and Antibody Testing on a Single Point of Care Platform

donderdag 5 augustus 2021

LumiraDx at ECCMID 2021: Performance Data presented on the use of the LumiraDx Platform with LumiraDx SARS-CoV-2 Ag and Ab Test

vrijdag 9 juli 2021

LumiraDx Achieves CE Mark for Its High Sensitivity, High Throughput COVID-19 Molecular Test, RNA STAR Complete

vrijdag 2 juli 2021

LumiraDx High Sensitivity Point of Care Antigen Test Detects Against Leading Variants of Concern including Alpha, Beta, Gamma, and Delta

donderdag 24 juni 2021